• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

制剂与雾化器性能。

Formulations and nebulizer performance.

作者信息

O'Riordan Thomas G

机构信息

Pulmonary/Critical Care Division, Health Sciences Center, State University of New York at Stony Brook, Stony Brook, New York 11794-8172, USA.

出版信息

Respir Care. 2002 Nov;47(11):1305-12; discussion 1312-3.

PMID:12425745
Abstract

To deliver a drug by nebulization, the drug must first be dispersed in a liquid (usually aqueous) medium. After application of a dispersing force (either a jet of gas or ultrasonic waves), the drug particles are contained within the aerosol droplets, which are then inhaled. Some drugs readily dissolve in water, whereas others need a cosolvent such as ethanol or propylene glycol. Some drugs are delivered as suspensions, and the efficiency of nebulizers can be different for solutions and suspensions. Solutions are delivered more efficiently with most devices. In general, conventional ultrasonic nebulizers should not be used to aerosolize suspensions, because of low efficiency. Newer strategies to improve the delivery of non-water-soluble drugs include the use of liposomes and the milling of the drug into very small "nanoparticles." In addition to the active therapeutic ingredient and solvents, drug formulations may include buffers (the solubility of some medications is influenced by pH), stabilizers, and, in the case of multi-dose preparations, antibacterial agents. Though formulations are designed to optimize drug solubility and stability, changes in formulation can also affect inhaled mass, particle size, and treatment time, though the differences between nebulizer brands probably have a greater impact than differences in formulation. Ultrasonic and jet nebulizers may damage protein and other complex agents through heat or shear stress. Additives to multi-dose formulations, especially antimicrobial and chelating agents, may cause adverse events, so there is a trend towards single-use, preservative-free vials.

摘要

通过雾化给药时,药物必须首先分散在液体(通常为水性)介质中。在施加分散力(气体射流或超声波)后,药物颗粒包含在气溶胶液滴中,然后被吸入。一些药物易溶于水,而其他药物则需要助溶剂,如乙醇或丙二醇。一些药物以混悬液形式给药,雾化器对溶液和混悬液的效率可能不同。大多数设备对溶液的给药效率更高。一般来说,传统的超声雾化器不应用于雾化混悬液,因为效率较低。改善非水溶性药物给药的新策略包括使用脂质体以及将药物研磨成非常小的“纳米颗粒”。除了活性治疗成分和溶剂外,药物制剂可能包括缓冲剂(某些药物的溶解度受pH值影响)、稳定剂,对于多剂量制剂,还包括抗菌剂。尽管制剂旨在优化药物的溶解度和稳定性,但制剂的变化也会影响吸入量、粒径和治疗时间,不过雾化器品牌之间的差异可能比制剂差异产生的影响更大。超声雾化器和喷射雾化器可能会通过热或剪切应力破坏蛋白质和其他复杂成分。多剂量制剂中的添加剂,尤其是抗菌剂和螯合剂,可能会引起不良事件,因此有向一次性、无防腐剂小瓶发展的趋势。

相似文献

1
Formulations and nebulizer performance.制剂与雾化器性能。
Respir Care. 2002 Nov;47(11):1305-12; discussion 1312-3.
2
Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.由基于乙醇的前体脂质体制备的制剂,用于通过医用雾化器给药。
J Pharm Pharmacol. 2006 Jul;58(7):887-94. doi: 10.1211/jpp.58.7.0002.
3
Design principles of liquid nebulization devices currently in use.当前使用的液体雾化装置的设计原理。
Respir Care. 2002 Nov;47(11):1257-75; discussion 1275-8.
4
Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol.使用带有多个小孔的振动网或板来产生气雾剂的雾化器。
Respir Care. 2002 Dec;47(12):1406-16; discussion 1416-8.
5
Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.使用空气喷射雾化器和具有大网孔的新型微泵装置递送的脂质体的物理稳定性和气溶胶特性。
Int J Pharm. 2007 Apr 4;334(1-2):62-70. doi: 10.1016/j.ijpharm.2006.10.022. Epub 2006 Oct 21.
6
Liquid nebulization: emerging technologies conference summary.
Respir Care. 2002 Dec;47(12):1471-6.
7
Factors influencing polycation/siRNA colloidal stability toward aerosol lung delivery.影响多阳离子/siRNA 胶态稳定性以实现气溶胶肺部递药的因素。
Eur J Pharm Biopharm. 2012 Jan;80(1):14-24. doi: 10.1016/j.ejpb.2011.08.008. Epub 2011 Sep 6.
8
Fabrication, characterization and optimization of nanostructured lipid carrier formulations using Beclomethasone dipropionate for pulmonary drug delivery via medical nebulizers.使用二丙酸倍氯米松制备、表征和优化载药纳米脂质体配方,通过医用雾化器进行肺部药物输送。
Int J Pharm. 2021 Apr 1;598:120376. doi: 10.1016/j.ijpharm.2021.120376. Epub 2021 Feb 20.
9
Aerosol delivery devices in the treatment of asthma.用于治疗哮喘的气雾剂输送装置。
Respir Care. 2008 Jun;53(6):699-723; discussion 723-5.
10
Stabilizing protein formulations during air-jet nebulization.在空气喷射雾化过程中稳定蛋白质配方。
Int J Pharm. 2010 Dec 15;402(1-2):140-5. doi: 10.1016/j.ijpharm.2010.09.042. Epub 2010 Oct 7.

引用本文的文献

1
Improving Pulmonary Delivery of Budesonide Suspensions Nebulized with Constant-Output Vibrating Mesh Nebulizers by Using Valved Holding Chamber.使用带阀储雾罐提高布地奈德混悬液经恒流振动筛网雾化器雾化后的肺部给药效果
Pharmaceutics. 2025 May 26;17(6):696. doi: 10.3390/pharmaceutics17060696.
2
Practical Considerations in Dose Extrapolation from Animals to Humans.从动物到人剂量外推的实际考虑。
J Aerosol Med Pulm Drug Deliv. 2024 Apr;37(2):77-89. doi: 10.1089/jamp.2023.0041. Epub 2024 Jan 17.
3
Aerosol therapy in adult critically ill patients: a consensus statement regarding aerosol administration strategies during various modes of respiratory support.
成人危重症患者的雾化治疗:关于不同呼吸支持模式下雾化给药策略的共识声明。
Ann Intensive Care. 2023 Jul 12;13(1):63. doi: 10.1186/s13613-023-01147-4.
4
Influence of Physicochemical Properties of Budesonide Micro-Suspensions on Their Expected Lung Delivery Using a Vibrating Mesh Nebulizer.布地奈德微悬浮液的物理化学性质对其使用振动网式雾化器预期肺部给药的影响。
Pharmaceutics. 2023 Feb 23;15(3):752. doi: 10.3390/pharmaceutics15030752.
5
Inhalation delivery technology for genome-editing of respiratory diseases.用于呼吸道疾病基因编辑的吸入式递药技术。
Adv Drug Deliv Rev. 2021 Jan;168:217-228. doi: 10.1016/j.addr.2020.06.001. Epub 2020 Jun 5.
6
Effective nebulization of interferon-γ using a novel vibrating mesh.新型振动网式雾化干扰素γ的效果。
Respir Res. 2019 Apr 3;20(1):66. doi: 10.1186/s12931-019-1030-1.
7
Nebulised antibiotherapy: conventional versus nanotechnology-based approaches, is targeting at a nano scale a difficult subject?雾化抗生素疗法:传统方法与基于纳米技术的方法,在纳米尺度上进行靶向治疗是一个难题吗?
Ann Transl Med. 2017 Nov;5(22):448. doi: 10.21037/atm.2017.09.17.
8
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System.使用仅经鼻暴露系统向小鼠递送药物的干粉和雾化气溶胶吸入法。
J Vis Exp. 2017 Apr 6(122):55454. doi: 10.3791/55454.
9
Inhaled Antibiotics for Gram-Negative Respiratory Infections.用于革兰氏阴性菌呼吸道感染的吸入性抗生素
Clin Microbiol Rev. 2016 Jul;29(3):581-632. doi: 10.1128/CMR.00101-15.
10
Nanodisks derived from amphotericin B lipid complex.两性霉素B脂质复合物衍生的纳米盘。
J Pharm Sci. 2008 Oct;97(10):4425-32. doi: 10.1002/jps.21325.